Ticagrelor removal by CytoSorb® in patients requiring emergent or urgent cardiac surgery: a UK-based cost-utility analysis
<br/><strong>Background: </strong>Acute coronary syndrome patients receiving dual antiplatelet therapy who need emergent or urgent cardiac surgery are at high risk of major bleeding, which can impair postoperative outcomes. CytoSorb®, a blood purification technology based on adsorb...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Publicado em: |
Springer Nature
2019
|